Indivior Pharmaceuticals, Inc. (DELISTED) (INDV:DL)
36.28
+0.91
(+2.57%)
USD |
NASDAQ |
Nov 02, 16:00
Indivior Pharmaceuticals Market Cap : 4.281B for Nov. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 4.281B |
| October 30, 2026 | 4.174B |
| October 29, 2026 | 4.160B |
| October 28, 2026 | 4.103B |
| October 27, 2026 | 4.097B |
| October 26, 2026 | 4.078B |
| October 23, 2026 | 4.067B |
| October 22, 2026 | 4.169B |
| October 21, 2026 | 4.105B |
| October 20, 2026 | 4.103B |
| October 19, 2026 | 3.997B |
| October 16, 2026 | 3.829B |
| October 15, 2026 | 3.967B |
| October 14, 2026 | 4.031B |
| October 13, 2026 | 4.180B |
| October 12, 2026 | 4.255B |
| October 09, 2026 | 4.228B |
| October 08, 2026 | 4.183B |
| October 07, 2026 | 4.263B |
| October 06, 2026 | 4.236B |
| October 05, 2026 | 4.247B |
| October 02, 2026 | 4.214B |
| October 01, 2026 | 4.175B |
| September 30, 2026 | 4.230B |
| September 29, 2026 | 4.318B |
| Date | Value |
|---|---|
| September 28, 2026 | 4.352B |
| September 25, 2026 | 4.227B |
| September 24, 2026 | 4.248B |
| September 23, 2026 | 4.237B |
| September 22, 2026 | 4.270B |
| September 21, 2026 | 4.193B |
| September 18, 2026 | 4.116B |
| September 17, 2026 | 4.211B |
| September 16, 2026 | 4.053B |
| September 15, 2026 | 4.038B |
| September 14, 2026 | 4.067B |
| September 11, 2026 | 4.070B |
| September 10, 2026 | 4.072B |
| September 09, 2026 | 4.103B |
| September 08, 2026 | 4.050B |
| September 04, 2026 | 4.123B |
| September 03, 2026 | 4.110B |
| September 02, 2026 | 4.136B |
| September 01, 2026 | 4.078B |
| August 31, 2026 | 4.122B |
| August 28, 2026 | 4.115B |
| August 27, 2026 | 4.165B |
| August 26, 2026 | 4.227B |
| August 25, 2026 | 4.244B |
| August 24, 2026 | 4.269B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.640B |
| Bristol Myers Squibb Co. | 126.14B |
| Eli Lilly & Co. | 1.327T |
| Ligand Pharmaceuticals, Inc. | 6.271B |
| Amneal Pharmaceuticals, Inc. | 6.454B |
Market Cap Related Metrics
| PE Ratio | 10.04 |
| PS Ratio | 3.301 |
| PEG Ratio | 0.0391 |
| Price to Free Cash Flow | 174.59 |
| Price | 36.28 |
| Earnings Yield | 9.96% |
| Operating PE Ratio | 7.326 |
| Normalized PE Ratio | 8.857 |